Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy
The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background and Aims: The MASH Resolution Index (MASHResInd) and FibroScan–aspartate aminotransferase (FAST) score have been reported to noninvasively predict the resolution of metabolic dysfunction–associated steatohepatitis (MASH) on histology. This study aimed to examine head-to-head the diagnostic accuracy of the MASHResInd versus FAST score in detecting MASH resolution. Approach and Results: This prospective study included 160 participants (64% female) with biopsy-proven MASH and stage 2 or stage 3 fibrosis from a randomized, multicenter trial of pegozafermin. Participants received either pegozafermin or placebo and underwent contemporaneous liver biopsies, magnetic resonance imaging-proton density fat fraction, and vibration-controlled transient elastography at 2-time points spaced 24 weeks apart. The primary objective was the detection of MASH resolution with no worsening of fibrosis. Diagnostic models were assessed by the area under the receiver operating characteristic curves (AUC) and compared with the Delong test. The median (IQR) age and body mass index of participants were 56.0 (49.0–62.0) years and 36.5 (32.2–40.4) kg/m 2 , respectively. The MASHResInd outperformed FAST for identifying MASH resolution without worsening fibrosis (AUC: 0.83, 95% CI: 0.75–0.91 vs. 0.65, 95% CI: 0.55–0.75, p =0.001). The positive predictive values for MASH resolution were 29% and 26% for the MASHResInd and FAST using rule-in criteria, respectively. The negative predictive values were 100% and 94% for the MASHResInd and FAST using rule-out criteria, respectively. Conclusions: The MASHResInd is better than the FAST score in the noninvasive prediction of MASH resolution. These data may have implications for clinical practice and trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent prospective, biopsy-controlled head-to-head study, the MASH-RI significantly outperformed the FAST score in detecting MASH resolution, with a higher AUC (0.83 vs. 0.65, p = 0.001) and higher negative predictive value (100% vs. 94%)”
From Aerobic Exercise Training Leads to MASH Resolution as Defined by the MASH Resolution Index (2026) · cites this paper as [30]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationSampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Self-citationNoninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Self-citationTreatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
Newsome, P. N., Sasso, M., Deeks, J. J., Paredes, A., Boursier, J., Chan, W.-K., Yilmaz, Y., Czernichow, S., Zheng, M.-H., Wong, V. W.-S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30383-8 · Cited by 800
Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El-Serag, H. B., & Loomba, R. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.003 · Cited by 534
Self-citation
Cited by
Ajmera, V. H., Vuppalanchi, R., Khalili, M., Sheikh, M. Y., Risser, J. A., Klein, S., Tincopa, M. A., Madamba, E. V., Singh, S., Siddiqi, H., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70516 · Cited by 17
Self-citationSOUZA, M. M. X. D., Al‐Sharif, L., Antunes, V., Wong, S. Y., Huang, D. Q., & Loomba, R. S. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70565 · Cited by 13
Self-citationSharpton, S. R., Díaz, L. A., Pepin, K. M., Amangurbanova, M., Madamba, E. V., Bettencourt, R., Singh, S., Valasek, M. A., Dalupang, M., Tesfai, K., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70696 · Cited by 8
Self-citationPlasma inflammatory proteome profiles identify MASLD among children with overweight or obesity
Wang, Y., Huang, D. Q., Zhang, P., Wang, M., Wu, Y., Nur, E., Li, L., & Wang, H. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03011-0 · Cited by 6
Self-citationBiopsy-free endpoints in MASH trials: A comparative look at MASHResInd and FAST
Ravaioli, F. (2025) · Hepatology · doi:10.1097/hep.0000000000001421 · Cited by 3
Metadata
- Authors
- Loomba, R., Daniel, P. C.-Y. N., Amangurbanova, M., Bettencourt, R., Madamba, E., Siddiqi, H., Richards, L., Gottwald, M. D., Feng, S., Margalit, M., & Huang, D. Q.
- Affiliations
- University of California San Diego (US)
- National University Health System (SG)
- 89bio (United States) (US)
- 89bio, Rehovot, Israel
- National University of Singapore (SG)
- Corresponding author
- Loomba, Rohit
- Daniel, Peter Chen-Yang Nikhil
- Huang, Daniel Q.
- ORCID
- Venue
- Hepatology
- Published
- 2025-05-09
- Volume
- 83
- Issue
- 4
- Pages
- 907-914
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W4410344661
- Cited by
- 17
- References
- 44
- Citations by year
- 2026: 12 · 2025: 5
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- nonalcoholic steatohepatitis, FAST score, non-invasive prediction, liver fibrosis, vibration-controlled transient elastography, liver biopsy, diagnostic accuracy
- MeSH terms
- Aspartate Aminotransferases, Biopsy, Fatty Liver, Female, Humans, Liver, Liver Cirrhosis, Magnetic Resonance Imaging, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, ROC Curve, Elasticity Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy. https://app.cochat.ai/papers/10.1097/hep.0000000000001396
- The paper
- Loomba, R., Daniel, P. C.-Y. N., Amangurbanova, M., Bettencourt, R., Madamba, E., Siddiqi, H., Richards, L., Gottwald, M. D., Feng, S., Margalit, M., & Huang, D. Q. (2026). Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy. Hepatology. https://doi.org/10.1097/hep.0000000000001396
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.